Sussex Formulary
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
    • Sussex-wide protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
    • 2025
    • 2024
    • 2023
  • APC Minutes
    • 2021
    • 2022
    • 2023
    • 2024
    • 2025
    • 2026
  • Discontinuations
  • Contact us
  • About The Formulary
  • Using The Formulary
  • Therapeutic Sections
    • 1 Gastro-intestinal system
    • 2 Cardiovascular system
    • 3 Respiratory system
    • 4 Nervous system
    • 5 Infection
    • 6 Endocrine system
    • 7 Genito-urinary system
    • 8 Immune system & malignant disease
      • Immune system
      • 8.1 Immune system disorders and transplantation
      • Malignant disease
      • 8.2 Antibody responsive malignancy
      • 8.3 Carcinoid syndrome
      • 8.4 Cytotoxic responsive malignancy
      • 8.5 Hormone responsive malignancy
        • 8.5.1 Hormone responsive breast cancer
      • 8.6 Immunotherapy responsive malignancy
      • 8.7 Photodynamic therapy responsive malignancy
      • 8.8 Targeted therapy responsive malignancy
      • 8.9 Other Immune system & malignant disease items
    • 9 Blood and nutrition
    • 10 Musculoskeletal system
    • 11 Eye
    • 12 Ear, nose and oropharynx
    • 13 Skin
    • 14 Vaccines
    • 15 Anaesthesia
    • 16 Emergency treatment of poisoning
    • 17 Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum
    • Appendix 1 - Borderline substances
    • Appendix 2 - Wound management products and elasticated garments
    • Appendix 3 - Continence
    • Appendix 4 - Palliative care
  • Drug Index
  • Antimicrobial Guidance
  • Shared Care Protocols
  • Position statements
  • Not Recommended Items
  • APC Summaries
  • APC Minutes
  • Discontinuations
  • Contact us
  • Search

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Anastrozole

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Anastrozole 1mg tablets

Pack
28 tablet
84 tablet

Exemestane

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Exemestane 25mg tablets

Pack
15 tablet
90 tablet
30 tablet

Fulvestrant

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Fulvestrant 250mg/5ml solution for injection pre-filled syringes

Pack
1 pre-filled disposable injection
2 pre-filled disposable injection

Letrozole

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Letrozole 2.5mg tablets

Pack
14 tablet
28 tablet
30 tablet

Letrozole 2.5mg/5ml oral suspension

Pack
1 ml

Megestrol

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Megestrol 160mg tablets

Pack
30 tablet

Tamoxifen

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Tamoxifen 10mg tablets

Pack
30 tablet

Tamoxifen 20mg tablets

Pack
30 tablet

Tamoxifen 40mg tablets

Pack
30 tablet

Tamoxifen 10mg/5ml oral solution

Pack
1 ml

Tamoxifen 10mg/5ml oral solution sugar free

Pack
150 ml

Tamoxifen 20mg/5ml oral solution

Pack
1 ml

Tamoxifen 40mg/5ml oral solution

Pack
1 ml

Online Formulary by M.O.M. Systems

NICE guidance is available from https://www.nice.org.uk/guidance All rights reserved. Subject to Notice of rights.
NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication.

© Copyright 2026